Certara, Inc. (CERT) Revenue History
Certara, Inc. (CERT) annual and quarterly revenue history with charts. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2021-12-31 | $286.10M |
| 2022-12-31 | $335.64M |
| 2023-12-31 | $354.34M |
| 2024-12-31 | $385.15M |
| 2025-12-31 | $418.84M |
How CERT compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| VCYT | Veracyte Inc. | $517.14M |
| ADMA | ADMA Biologics Inc | $510.17M |
| KRYS | Krystal Biotech Inc. | $389.13M |
| MNKD | MannKind Corporation | $348.97M |
| FLGT | Fulgent Genetics Inc. | $322.67M |
These are five companies in the same sector as CERT with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Certara, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("CERT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CERT | $8.13 | +0.74% | 2.35M |
| 3 | ||||
| 4 | ||||
| 5 |